113 related articles for article (PubMed ID: 22694167)
21. Drug search for leishmaniasis: a virtual screening approach by grid computing.
Ochoa R; Watowich SJ; Flórez A; Mesa CV; Robledo SM; Muskus C
J Comput Aided Mol Des; 2016 Jul; 30(7):541-52. PubMed ID: 27438595
[TBL] [Abstract][Full Text] [Related]
22. Assessing the polyamine metabolism of Plasmodium falciparum as chemotherapeutic target.
Müller IB; Das Gupta R; Lüersen K; Wrenger C; Walter RD
Mol Biochem Parasitol; 2008 Jul; 160(1):1-7. PubMed ID: 18455248
[TBL] [Abstract][Full Text] [Related]
23. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
24. Spermidine synthase is required for virulence of Leishmania donovani.
Gilroy C; Olenyik T; Roberts SC; Ullman B
Infect Immun; 2011 Jul; 79(7):2764-9. PubMed ID: 21536795
[TBL] [Abstract][Full Text] [Related]
25. Polyamine metabolism in Leishmania: from arginine to trypanothione.
Colotti G; Ilari A
Amino Acids; 2011 Feb; 40(2):269-85. PubMed ID: 20512387
[TBL] [Abstract][Full Text] [Related]
26. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis.
Goyal S; Grover S; Dhanjal JK; Goyal M; Tyagi C; Chacko S; Grover A
J Mol Model; 2014 Mar; 20(3):2099. PubMed ID: 24567150
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
[TBL] [Abstract][Full Text] [Related]
29. Structural requirements for novel coenzyme-substrate derivatives to inhibit intracellular ornithine decarboxylase and cell proliferation.
Wu F; Gehring H
FASEB J; 2009 Feb; 23(2):565-74. PubMed ID: 18922879
[TBL] [Abstract][Full Text] [Related]
30. Novel Inhibitors of Ornithine Decarboxylase of Leishmania Parasite (LdODC): The Parasite Resists LdODC Inhibition by Overexpression of Spermidine Synthase.
Das M; Singh S; Dubey VK
Chem Biol Drug Des; 2016 Mar; 87(3):352-60. PubMed ID: 26362015
[TBL] [Abstract][Full Text] [Related]
31. A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 1-amino-oxy-3-aminopropane.
Dufe VT; Ingner D; Heby O; Khomutov AR; Persson L; Al-Karadaghi S
Biochem J; 2007 Jul; 405(2):261-8. PubMed ID: 17407445
[TBL] [Abstract][Full Text] [Related]
32. Polyamine biosynthesis in Phytomonas: biochemical characterisation of a very unstable ornithine decarboxylase.
Marcora MS; Cejas S; González NS; Carrillo C; Algranati ID
Int J Parasitol; 2010 Oct; 40(12):1389-94. PubMed ID: 20406645
[TBL] [Abstract][Full Text] [Related]
33. Computational study on the inhibition mechanism of cruzain by nitrile-containing molecules.
Méndez-Lucio O; Romo-Mancillas A; Medina-Franco JL; Castillo R
J Mol Graph Model; 2012 May; 35():28-35. PubMed ID: 22481076
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel S-adenosyl-L-homocysteine hydrolase inhibitors through homology-model-based virtual screening, synthesis, and biological evaluation.
Khare P; Gupta AK; Gajula PK; Sunkari KY; Jaiswal AK; Das S; Bajpai P; Chakraborty TK; Dube A; Saxena AK
J Chem Inf Model; 2012 Mar; 52(3):777-91. PubMed ID: 22324915
[TBL] [Abstract][Full Text] [Related]
35. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
Ghoda L; Basu HS; Porter CW; Marton LJ; Coffino P
Mol Pharmacol; 1992 Aug; 42(2):302-6. PubMed ID: 1513327
[TBL] [Abstract][Full Text] [Related]
36. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
37. Flavones reversibly inhibit Leishmania donovani tyrosine aminotransferase by binding to the catalytic pocket: An integrated in silico-in vitro approach.
Sasidharan S; Saudagar P
Int J Biol Macromol; 2020 Dec; 164():2987-3004. PubMed ID: 32798546
[TBL] [Abstract][Full Text] [Related]
38. Modeling of babesipain-1 and identification of natural and synthetic leads for bovine babesiosis drug development.
Meetei PA; Rathore RS; Prabhu NP; Vindal V
J Mol Model; 2016 Apr; 22(4):71. PubMed ID: 26969677
[TBL] [Abstract][Full Text] [Related]
39. L. donovani XPRT: Molecular characterization and evaluation of inhibitors.
Patel B; Patel D; Parmar K; Chauhan R; Singh DD; Pappachan A
Biochim Biophys Acta Proteins Proteom; 2018 Mar; 1866(3):426-441. PubMed ID: 29233758
[TBL] [Abstract][Full Text] [Related]
40. Identification of Plasmodium falciparum spermidine synthase active site binders through structure-based virtual screening.
Jacobsson M; Gäredal M; Schultz J; Karlén A
J Med Chem; 2008 May; 51(9):2777-86. PubMed ID: 18410081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
